<span item_type="fundamental" item_id="5eb889a1e342b96b382f7164ae851371" counter_id="ST/US/IVP" env="prod"></span><span item_type="announcement" item_id="549078831320663298" env="prod"></span><p>Revenue: As of FY2025 Q2, the actual value is USD 4.284 M.</p><p>EPS: As of FY2025 Q2, the actual value is USD -0.5.</p><p>EBIT: As of FY2025 Q2, the actual value is USD -3.035 M.</p><p></p><h3>Segment Revenue</h3><ul><li><strong>Service Revenue</strong>: $5,936,295 for the six months ended June 30, 2025, compared to $6,765,837 for the same period in 2024, representing a decrease of 12%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1939365/000121390025075645/ea0252765-10q_inspire.htm"></span></li><li><strong>Product Revenue</strong>: $1,986,448 for the six months ended June 30, 2025, compared to $2,456,111 for the same period in 2024, representing a decrease of 19%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1939365/000121390025075645/ea0252765-10q_inspire.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Loss</strong>: $5,449,604 for the six months ended June 30, 2025, compared to $6,808,213 for the same period in 2024, representing a decrease of 20%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1939365/000121390025075645/ea0252765-10q_inspire.htm"></span></li><li><strong>Total Operating Expenses</strong>: $12,545,588 for the six months ended June 30, 2025, compared to $14,478,053 for the same period in 2024, representing a decrease of 13%.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1939365/000121390025075645/ea0252765-10q_inspire.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Net Cash Used in Operating Activities</strong>: $2,272,581 for the six months ended June 30, 2025, compared to $3,019,312 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1939365/000121390025075645/ea0252765-10q_inspire.htm"></span></li><li><strong>Net Cash Used in Investing Activities</strong>: $1,882,854 for the six months ended June 30, 2025, compared to $180,636 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1939365/000121390025075645/ea0252765-10q_inspire.htm"></span></li><li><strong>Net Cash Provided by Financing Activities</strong>: $3,825,187 for the six months ended June 30, 2025, compared to $3,028,645 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1939365/000121390025075645/ea0252765-10q_inspire.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Adjusted Clinics EBITDA</strong>: $286,646 for the six months ended June 30, 2025, compared to $162,976 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1939365/000121390025075645/ea0252765-10q_inspire.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company plans to continue acquiring existing general practice, specialty hospitals, and expand existing locations to include emergency care and more complex surgeries, holistic care, and comprehensive diagnostics.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1939365/000121390025075645/ea0252765-10q_inspire.htm"></span></li><li><strong>Non-Core Business</strong>: The company has entered the equine care sector with the addition of the Pony Express Veterinary Hospital and plans to expand into emergency care and mixed animal care in future years.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1939365/000121390025075645/ea0252765-10q_inspire.htm"></span></li></ul><h3>Priority</h3><ul><li>The company emphasizes acquiring multi-unit practices with regional presence to facilitate growth and become a prime provider in select markets.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1939365/000121390025075645/ea0252765-10q_inspire.htm"></span></li></ul>

Inspire Veterinary Partners | 10-Q: FY2025 Q2 Revenue: USD 4.284 M